582 related articles for article (PubMed ID: 314300)
21. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
22. Metalophil histiocytes in non-Hodgkin's lymphomas particularly in malignant proliferations of B-lymphocytes.
Van Unnik JA; De Weger RA
J Pathol; 1984 Dec; 144(4):241-51. PubMed ID: 6084055
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
[TBL] [Abstract][Full Text] [Related]
24. Two maturation-associated mouse erythrocyte receptors of human B cells. I. Identification of four human B-cell subsets.
Forbes IJ; Zalewski PD; Valente L; Gee D
Clin Exp Immunol; 1982 Feb; 47(2):396-404. PubMed ID: 6978783
[TBL] [Abstract][Full Text] [Related]
25. Malignant lymphomas as tumours of the immune system.
Berard CW; Cossman J; Jaffe ES
Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
[TBL] [Abstract][Full Text] [Related]
26. Immunologic subsets in B cell lymphomas defined by surface immunoglobulin isotype and complement receptor--their relationship to survival.
Kvaløy S; Langholm R; Kaalhus O; Marton PF; Høst H; Godal T
Scand J Haematol; 1985 Aug; 35(2):137-44. PubMed ID: 3876595
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous B-cell lymphoma.
Burg G; Kaudewitz P; Klepzig K; Przybilla B; Braun-Falco O
Dermatol Clin; 1985 Oct; 3(4):689-704. PubMed ID: 3916175
[TBL] [Abstract][Full Text] [Related]
28. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
30. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
[TBL] [Abstract][Full Text] [Related]
31. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas.
Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P
Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576
[TBL] [Abstract][Full Text] [Related]
32. Terminal deoxynucleotidyl transferase activity in lymphoma.
Habeshaw JA; Catley PF; Stansfield AG; Ganeshaguru K; Hoffbrand AV
Br J Cancer; 1979 May; 39(5):566-9. PubMed ID: 314814
[TBL] [Abstract][Full Text] [Related]
33. Benign and malignant lymphoid lesions of the stomach. A histological reappraisal in the light of the Kiel classification for non-Hodgkin's lymphomas.
Vanden Heule B; Van Kerkem C; Heimann R
Histopathology; 1979 Jul; 3(4):309-20. PubMed ID: 468132
[TBL] [Abstract][Full Text] [Related]
34. The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1982 Jun; 49(11):2321-35. PubMed ID: 6804083
[TBL] [Abstract][Full Text] [Related]
35. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
[TBL] [Abstract][Full Text] [Related]
36. The incidence of B cell leukaemia and lymphopenia in B cell neoplasia in adults: a study using the Kiel classification of non-Hodgkin's lymphoma.
Cader A; Richardson P; Walsh L; Ling NR; MacLennan IC; Jones EL; Leyland M
Br J Cancer; 1983 Aug; 48(2):185-93. PubMed ID: 6603860
[TBL] [Abstract][Full Text] [Related]
37. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
38. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T
Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
[TBL] [Abstract][Full Text] [Related]
39. Characterization of B-cell non-Hodgkin's lymphomas. A study using a panel of monoclonal and heterologous antibodies.
van der Valk P; Jansen J; Daha MR; Meijer CJ
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):289-305. PubMed ID: 6195805
[TBL] [Abstract][Full Text] [Related]
40. [B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum].
Schwarze EW; Pileri S; Stein H; Palestro G; Tolksdorf G
Klin Padiatr; 1982; 194(4):226-32. PubMed ID: 6982372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
